• NAD+ Workflows for Energy-Stress Research

  2026-08-18

  Build reproducible NAD+ experiments for redox assays, metabolic signaling, autophagy, and enzyme studies. This practical guide links NAD+ handling to the AMPK–ULK1 findings that can change how energy-stress experiments are designed and interpreted.

• In Vitro Drug Response Metrics in Cancer Research

  2026-08-18

  Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable readouts of anticancer activity. Its central practical implication is that drug-response studies should distinguish proliferative arrest from cell killing and account for their different proportions and timing.

• Network Medicine Identifies Apigenin in Alzheimer’s Models

  2026-08-17

  Ding and colleagues used network proximity analysis to screen flavonoids against Alzheimer’s disease targets, prioritizing Apigenin as the strongest candidate among experimentally tested compounds. Cellular validation linked its neuroprotective activity to preservation of mitochondrial function, reduced apoptosis, AKT/NF-κB pathway modulation, and regulation of microglial inflammatory states.

• NAD+ and the Next Frontier of Cell-Stress Biology

  2026-08-17

  The latest human breast cancer research reframes caspase 3 and caspase 7 as stress-adaptation regulators rather than apoptosis-only proteases. This article shows how NAD+ biology can be strategically integrated with autophagy, PARP1, DNA damage, and BRCA1 studies without overstating what current evidence proves.

• AMG 487 CXCR3 Antagonist Workflow

  2026-08-16

  AMG 487 is a potent, selective CXCR3 antagonist for dissecting chemokine-driven migration, calcium signaling, and macrophage polarization. This practical workflow connects assay design with the CXCL10–CXCR3–LAMP1 findings reported in inflammatory research while highlighting solvent, metabolism, and cell-state controls.

• LDH Cytotoxicity Assay Kit Workflow Guide

  2026-08-15

  The LDH Cytotoxicity Assay Kit provides a non-radioactive method for cell cytotoxicity measurement by detecting LDH released after membrane damage. It is suitable for comparative cell injury and viability studies, but it should not be used alone to identify a specific death pathway or provide single-cell apoptosis resolution.

• Oleic Acid: From Lipid Model to Translation

  2026-08-14

  Oleic Acid is more than a lipid supplement: it is a controllable perturbation tool for connecting membrane biology, lipid metabolism, inflammation, and signaling to translational disease models. This article interprets recent hepatic ischemia-reperfusion research and translates it into practical experimental strategy.

• Lypressin Acetate: From GPCR Biology to Translation

  2026-08-14

  Lypressin acetate, also known as Lysine vasopressin acetate, offers translational researchers a mechanistically informative vasopressin receptor agonist for endocrine, vascular, hemostatic, and exploratory antiviral studies. This article connects receptor biology, assay design, product handling, competitive positioning, and the evidence boundaries required to move from a peptide signal to a credible development hypothesis.

• HyperScript First-Strand cDNA Synthesis Kit for AML

  2026-08-13

  Discover how the HyperScript First-Strand cDNA Synthesis Kit can support reliable AML gene-expression workflows, from low-copy gene reverse transcription to qPCR validation. This article translates MT2A perturbation findings in HL60 cells into practical primer, control, and RNA-quality decisions.

• Rat Claustrum Development and Nurr1 Gradients

  2026-08-13

  Fang, Wang, and Naumann map the developmental emergence and birth timing of Nurr1-positive neurons across the rat claustrum and lateral cortex. By combining embryonic Nurr1 in situ hybridization with EdU birth dating, the study identifies sequential neurogenesis and spatial gradients that refine how claustral subregions are defined.

• 5-Methyl-CTP for Translational mRNA Assays

  2026-08-12

  Learn how 5-Methyl-CTP can support mRNA synthesis with modified nucleotides, while the H5N1 dairy-cow vaccine study reveals practical assay and translational decisions. This evidence-focused guide separates established findings from workflow recommendations for mRNA drug development.

• Ciclesonide and the Next Logic of Translational Design

  2026-08-12

  Ciclesonide offers a precise model for studying local glucocorticoid activation, while new ERAD-hijacking work shows how intracellular routing can reshape drug discovery. Together, these findings suggest a disciplined translational framework that connects prodrug pharmacology, target engagement, and protein fate without conflating established respiratory evidence with emerging degradation technology.

• Caspase 3/7, Autophagy, and DNA Damage Response

  2026-08-11

  Samarasekera et al. show that caspases 3 and 7 have a non-apoptotic, cytoprotective role in human breast cancer cells exposed to non-lethal starvation or proteasome-inhibition stress. Their genetic, molecular, and rescue experiments connect effector caspases with autophagy, PARP1 regulation, H2AX phosphorylation, and a synthetic-lethal interaction with BRCA1 loss.

• Zolmitriptan: From Receptor Signal to Translation

  2026-08-11

  A translational framework for using Zolmitriptan as a selective serotonin receptor tool in migraine and cluster headache research, with practical guidance on assay design, compound handling, mechanistic validation, and cross-domain lessons from lysosomal biology.

• ERADECs: ERAD Hijacking for Membrane Protein Degradation

  2026-08-10

  Song et al. establish ERAD-engaging chimeras (ERADECs), a small-molecule targeted protein degradation platform that redirects transmembrane proteins to the ER-associated degradation pathway. By using desonide to engage the ER E3 ligase SYVN1, the study achieves highly effective PD-L1 degradation and demonstrates functional tumor suppression, while defining opportunities and constraints for broader membrane-protein targeting.

11509 records 1/768 page Next 12345 下5页 Last page